跳至主要内容
临床试验/CTRI/2025/01/078848
CTRI/2025/01/078848尚未招募2 期

Evaluation of Shiroabhyanga with Panchgavya Ghrita Matra Basti in the Management of Attention Deficit Hyperactivity Disorder

Dr Puja CN Pathak1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年1月21日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
Panchgavya Ghrita Matrabasti alongwith Brahmi Taila Shiro Abhyanga is effective in the management of ADHD in children.

研究概览

简要总结

The global prevalence of ADHD in children and adolescents is estimated to be around 8.0 %, with a higher occurrence in males. In India, the prevalence varies between 2% to 17%.3,4

The immediate and long-term consequences of untreated or under-treated ADHD can be quite severe for children, their families, and society .5 Covid -19 pandemic have shown significant adverse impacts on a child with neurodevelopmental conditions such as ADHD

In Modern Science, the treatment of ADHD involves Methylphenidate and Amphetamine, which are psychostimulant drugs. Adverse reactions of the drug includes decreased appetite, irritability, tics, sleep issues, with an increased risk of cardiovascular events. Prolonged use, causes slowing of physical growth which is transient with an unclear cause6

ADHD is comparable to Unmada which is described as a disorder of the manovaha srotas. Ghrita is mentioned as a remedy for Unmada in Caraka

Samhita Sutrasthana Annapanvidhi Adhyaya.7

In Ayurveda there are many drugs like Kalyanaka Ghrita, Panchgavya Ghrita, Brahmi Churna, Vachadi churna etc. that are known to be used in Manovaha srotas vikaras as aushadhi and may be helpful in handling ADHD like conditions more effectively.

研究设计

研究类型
Interventional

入排标准

年龄范围
6.00 Year(s) 至 12.00 Year(s)(—)
性别
All

入选标准

  • Participants in between age group of 6-12 years.
  • All participants will be included irrespective of Sex, religion, and socioeconomic status.
  • Children without any acute illness and brain trauma.
  • Children in whom parents are willing to sign the written consent form to participate.

排除标准

  • Children with an acute or chronic, local or systemic infection will be excluded.
  • Known case of cerebral palsy, mental retardation and epilepsy, hearing defect etc.
  • Children who have received any form of modern intervention for ADHD in last 1 year.
  • Children in whom parents are hesitant to sign the written consent form to participate.

结局指标

主要结局

Panchgavya Ghrita Matrabasti alongwith Brahmi Taila Shiro Abhyanga is effective in the management of ADHD in children.

时间窗: 30 days of intervention and | frequency of assessment- 0th , 30th , 60th , 90th day.

次要结局

  • Panchgavya Ghrita Matrabasti alongwith Brahmi Taila Shiro Abhyanga is effective when compared with oral administration of Panchgavya Ghrita with Brahmi Taila Shiro Abhyanga in the management of ADHD in children.(30 days of intervention and)

研究者

发起方
Dr Puja CN Pathak
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Puja CN Pathak

Sri Sri College of Ayurvedic Science and Research Hospital, Cuttack, Odisha

研究点 (1)

Loading locations...

相似试验

Attention Deficit Hyperactivity Disorder | 临床试验